Free FIB-4 Calculator

FIB-4 Calculator — A Non-Invasive Liver Fibrosis Assessment Tool

The FIB-4 Calculator (also known as the Fibrosis-4 Calculator) is a widely used, non-invasive method for estimating the likelihood of advanced liver fibrosis, particularly in individuals with non‑alcoholic fatty liver disease (NAFLD). As an advanced fibrosis test, it helps clinicians rule out or confirm significant liver scarring without resorting to biopsy. This tool integrates the FIB-4 index and the APRI score to give you a more complete picture of your liver health — making it a practical NAFLD Fibrosis Calculator and APRI Score Calculator in one place.

How the FIB-4 Score Works

The FIB-4 index combines four variables that are routinely measured in blood tests:

• Age (in years)
• AST (aspartate aminotransferase, in U/L)
• ALT (alanine aminotransferase, in U/L)
• Platelet count (in ×10⁹/L)

The formula is:

$$\text{FIB-4} = \frac{\text{age} \times \text{AST}}{\text{platelet count} \times \sqrt{\text{ALT}}}$$

Note that the ALT value must be square‑rooted in the denominator.

Thresholds for Advanced Fibrosis

The FIB-4 score is most reliable for adults aged 35–65 years. Two key cut‑offs are used in clinical practice:

• FIB‑4 > 3.25 — confirms the presence of advanced fibrosis (stages F3–F4) with a specificity of about 82.1%.
• FIB‑4 < 1.45 — rules out advanced fibrosis with a negative predictive value of 94.7% (Vallet‑Pichard et al., 2009).

For patients outside the 35–65 age range, the test may yield a higher false‑positive rate, so results should be interpreted cautiously.

What You Need to Use the Calculator

To calculate your FIB‑4 score, you will need the results of three standard blood tests:

• AST (aspartate transaminase) — usually reported in U/L
• ALT (alanine transaminase) — usually reported in U/L
• Platelet count — expressed as number of platelets per µL or per ×10⁹/L

Most laboratory reports provide these values easily. Once you have them, the calculator will compute both the FIB‑4 index and the APRI ratio.

Understanding NAFLD and Liver Fibrosis

NAFLD (Non‑Alcoholic Fatty Liver Disease) is the most prevalent chronic liver condition worldwide. It is characterized by excessive fat accumulation in the liver without significant alcohol consumption. If left unmanaged, NAFLD can progress to cirrhosis and permanent loss of liver function.

It is important to distinguish NAFLD from NASH (Non‑Alcoholic SteatoHepatitis), which involves liver inflammation in addition to fat. The development of NAFLD and NASH is linked to several risk factors:

• Obesity and metabolic syndrome (including hypertension, type 2 diabetes)
• Certain drugs and toxins
• Inherited metabolic disorders

Chronic alcohol intake is another major cause of liver damage; the AUDIT‑C questionnaire may help screen for alcohol‑related risk.

The APRI Score — A Complementary Metric

The APRI Score Calculator is a simple ratio that estimates the probability of fibrosis progression, especially among patients with hepatitis C. The formula is:

$$\text{APRI} = \frac{\dfrac{\text{AST}}{\text{upper limit of normal AST}}}{\text{platelet count}}$$

Most guidelines use 40 U/L as the upper normal limit for AST. The interpretation:

• APRI ≥ 1.0 — high probability of severe fibrosis (cirrhosis); indicates an elevated risk of disease progression.
• APRI < 0.5 — rules out significant fibrosis in approximately 87% of cases.

Using both scores together provides a broader, non‑invasive liver assessment and helps guide clinical decisions.

Other Fibrosis Scores

While the FIB‑4 and APRI are popular due to their simplicity, other scoring systems exist — ranging from blood‑based indices (e.g., AST/ALT ratio, FibroTest) to more invasive approaches like liver biopsy. The choice of method depends on the clinical context and available resources.

Important: This non‑invasive liver assessment is a supportive tool and does not replace a professional medical evaluation. If you have concerns about your liver health, consult a qualified healthcare provider.